{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:08:15Z","timestamp":1791857295508,"version":"4.3.4"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,6,19]]},"DOI":"10.1001\/jama.2018.6228","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T16:31:05Z","timestamp":1529425865000},"page":"2401","source":"Crossref","is-referenced-by-count":533,"title":["Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer"],"prefix":"10.1001","volume":"319","author":[{"given":"Chunling","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven N.","family":"Hart","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Polley","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Gnanaolivu","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermela","family":"Shimelis","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun Y.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Lilyquist","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel O.","family":"Antwi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Bamlet","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari G.","family":"Chaffee","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"DiCarlo","sequence":"additional","affiliation":[{"name":"Qiagen Sciences Research and Development, Qiagen Inc, Hilden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wu","sequence":"additional","affiliation":[{"name":"Qiagen Sciences Research and Development, Qiagen Inc, Hilden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Samara","sequence":"additional","affiliation":[{"name":"Qiagen Sciences Research and Development, Qiagen Inc, Hilden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pashtoon M.","family":"Kasi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"McWilliams","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria M.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Couch","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9","key":"joi180051r1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations between cancer predisposition testing panel genes and breast cancer.","volume":"3","author":"Couch","year":"2017","journal-title":"JAMA Oncol"},{"issue":"7","key":"joi180051r2","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw302","article-title":"Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers.","volume":"109","author":"Kuchenbaecker","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"joi180051r3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1200\/JCO.2015.64.0730","article-title":"Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three European expert centers.","volume":"34","author":"Vasen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"joi180051r4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"issue":"5","key":"joi180051r5","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1053\/j.seminoncol.2016.09.002","article-title":"Familial pancreatic cancer.","volume":"43","author":"Petersen","year":"2016","journal-title":"Semin Oncol"},{"issue":"2","key":"joi180051r6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","article-title":"The prevalence of BRCA2 mutations in familial pancreatic cancer.","volume":"16","author":"Couch","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"joi180051r7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.","volume":"17","author":"Zhen","year":"2015","journal-title":"Genet Med"},{"issue":"1","key":"joi180051r8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/gim.2017.85","article-title":"Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.","volume":"20","author":"Chaffee","year":"2018","journal-title":"Genet Med"},{"issue":"18","key":"joi180051r9","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers.","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"joi180051r10","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1001\/jama.2009.1529","article-title":"Risk of pancreatic cancer in families with Lynch syndrome.","volume":"302","author":"Kastrinos","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"joi180051r11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1158\/1055-9965.EPI-15-0455","article-title":"Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients.","volume":"25","author":"Hu","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"30","key":"joi180051r12","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma.","volume":"35","author":"Shindo","year":"2017","journal-title":"J Clin Oncol"},{"issue":"10","key":"joi180051r13","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.v123.10","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.","volume":"123","author":"Buys","year":"2017","journal-title":"Cancer"},{"issue":"8","key":"joi180051r14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.","volume":"18","author":"Susswein","year":"2016","journal-title":"Genet Med"},{"issue":"7616","key":"joi180051r15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"issue":"D1","key":"joi180051r16","doi-asserted-by":"publisher","first-page":"D840","DOI":"10.1093\/nar\/gkw971","article-title":"The ExAC browser: displaying reference data information from over 60?000 exomes.","volume":"45","author":"Karczewski","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"joi180051r17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/carcin\/bgw022","article-title":"Pancreatic cancer: associations of inflammatory potential of diet, cigarette smoking and long-standing diabetes.","volume":"37","author":"Antwi","year":"2016","journal-title":"Carcinogenesis"},{"key":"joi180051r18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2164-15-63","article-title":"Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing.","volume":"15","author":"Lange","year":"2014","journal-title":"BMC Genomics"},{"issue":"20","key":"joi180051r19","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1200\/JCO.2016.71.6480","article-title":"Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer.","volume":"35","author":"Kurian","year":"2017","journal-title":"J Clin Oncol"},{"issue":"13","key":"joi180051r24","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/bioinformatics\/btu137","article-title":"The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation.","volume":"30","author":"Kocher","year":"2014","journal-title":"Bioinformatics"},{"issue":"3","key":"joi180051r25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/humu.2016.37.issue-3","article-title":"dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs.","volume":"37","author":"Liu","year":"2016","journal-title":"Hum Mutat"},{"issue":"D1","key":"joi180051r26","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants.","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"joi180051r27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13073-015-0195-6","article-title":"CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting.","volume":"7","author":"M\u00fcnz","year":"2015","journal-title":"Genome Med"},{"issue":"2","key":"joi180051r28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/bib\/bbv051","article-title":"VCF-Miner: GUI-based application for mining variants and annotations stored in VCF files.","volume":"17","author":"Hart","year":"2016","journal-title":"Brief Bioinform"},{"issue":"2","key":"joi180051r29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/biostatistics\/kxp050","article-title":"Confidence intervals that match Fisher\u2019s exact or Blaker\u2019s exact tests.","volume":"11","author":"Fay","year":"2010","journal-title":"Biostatistics"},{"issue":"16","key":"joi180051r31","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1200\/JCO.2015.63.3511","article-title":"Metformin use and survival of patients with pancreatic cancer: a cautionary lesson.","volume":"34","author":"Chaiteerakij","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"joi180051r32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"8","key":"joi180051r33","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","article-title":"ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.","volume":"38","author":"Renwick","year":"2006","journal-title":"Nat Genet"},{"issue":"43","key":"joi180051r34","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1038\/sj.onc.1209873","article-title":"ATM and breast cancer susceptibility.","volume":"25","author":"Ahmed","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"joi180051r35","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers.","volume":"97","author":"Thompson","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"joi180051r36","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","article-title":"Rare variants in the ATM gene and risk of breast cancer.","volume":"13","author":"Goldgar","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"3","key":"joi180051r38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation.","volume":"33","author":"Kaufman","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"joi180051r39","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1158\/2159-8290.CD-16-1250","article-title":"Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline BRCA1\/2 mutations and selected sporadic cancers.","volume":"7","author":"de Bono","year":"2017","journal-title":"Cancer Discov"},{"issue":"2","key":"joi180051r40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","article-title":"ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes.","volume":"110","author":"Syngal","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"joi180051r41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.gastro.2015.08.056","article-title":"Genetic diversity of pancreatic ductal adenocarcinoma and opportunities for precision medicine.","volume":"150","author":"Knudsen","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"joi180051r42","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.gastro.2012.01.005","article-title":"Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.","volume":"142","author":"Canto","year":"2012","journal-title":"Gastroenterology"},{"key":"joi180051r30","first-page":"35","volume-title":"Nonparametrics: Statistical Methods Based on Ranks","author":"Lehmann","year":"1998"},{"key":"joi180051r20","unstructured":"Cutadept. http:\/\/journal.embnet.org\/index.php\/embnetjournal\/article\/view\/200. Accessed May 31, 2018."},{"key":"joi180051r21","unstructured":"LiH. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. https:\/\/arxiv.org\/abs\/1303.3997. Accessed May 31, 2018."},{"key":"joi180051r22","unstructured":"Genotype quality. https:\/\/github.com\/samtools\/hts-specs\/. Accessed May 31, 2018."},{"key":"joi180051r23","unstructured":"GnomAD. http:\/\/gnomad.broadinstitute.org\/. Accessed March 10, 2018."},{"key":"joi180051r37","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma, Version 3. 2017. https:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/pancreatic.pdf. Accessed March 25, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2685154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T16:31:37Z","timestamp":1529425897000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.6228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":42,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,6,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.6228","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,19]]}}}